Cargando…
Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences
Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing clinically established radiopharmaceuticals. The aim of this study was to evaluate a GIPR-targeting positron...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864903/ https://www.ncbi.nlm.nih.gov/pubmed/36678558 http://dx.doi.org/10.3390/ph16010061 |
_version_ | 1784875700940963840 |
---|---|
author | Velikyan, Irina Bossart, Martin Haack, Torsten Laitinen, Iina Estrada, Sergio Johansson, Lars Pierrou, Stefan Wagner, Michael Eriksson, Olof |
author_facet | Velikyan, Irina Bossart, Martin Haack, Torsten Laitinen, Iina Estrada, Sergio Johansson, Lars Pierrou, Stefan Wagner, Michael Eriksson, Olof |
author_sort | Velikyan, Irina |
collection | PubMed |
description | Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing clinically established radiopharmaceuticals. The aim of this study was to evaluate a GIPR-targeting positron emission tomography (PET) radioligand with receptor-specific binding, fast blood clearance, and low liver background uptake. The peptide DOTA-bioconjugate, C803-GIP, was developed based on the sequence of the endogenous GIP(1-30) and synthetic exendin-4 peptides with selective amino acid mutations to combine their specificity for the GIPR and in vivo stability, respectively. The (68)Ga-labeled bioconjugate was evaluated in vitro in terms of binding affinity, specificity, and internalization in HEK293 cells transfected with the human GIPR, GLP1, or GCG receptors and in sections of human insulinoma and NENs. In vivo binding specificity, biodistribution, and tissue background were investigated in mice bearing huGIPR-HEK293 xenografts and in a pig. Ex vivo organ distribution, pharmacokinetics, and dosimetry were studied in normal rats. [(68)Ga]Ga-C803-GIP was stable and demonstrated a high affinity to the huGIPR-HEK293 cells. Binding specificity was demonstrated in vitro in frozen sections of NENs and huGIPR-HEK293 cells. No specific uptake was observed in the negative controls of huGLP1R and huGCGR cells. A novel rationally designed PET radioligand, [(68)Ga]Ga-C803-GIP, demonstrated promising binding characteristics and specificity towards the GIPR. |
format | Online Article Text |
id | pubmed-9864903 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98649032023-01-22 Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences Velikyan, Irina Bossart, Martin Haack, Torsten Laitinen, Iina Estrada, Sergio Johansson, Lars Pierrou, Stefan Wagner, Michael Eriksson, Olof Pharmaceuticals (Basel) Article Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing clinically established radiopharmaceuticals. The aim of this study was to evaluate a GIPR-targeting positron emission tomography (PET) radioligand with receptor-specific binding, fast blood clearance, and low liver background uptake. The peptide DOTA-bioconjugate, C803-GIP, was developed based on the sequence of the endogenous GIP(1-30) and synthetic exendin-4 peptides with selective amino acid mutations to combine their specificity for the GIPR and in vivo stability, respectively. The (68)Ga-labeled bioconjugate was evaluated in vitro in terms of binding affinity, specificity, and internalization in HEK293 cells transfected with the human GIPR, GLP1, or GCG receptors and in sections of human insulinoma and NENs. In vivo binding specificity, biodistribution, and tissue background were investigated in mice bearing huGIPR-HEK293 xenografts and in a pig. Ex vivo organ distribution, pharmacokinetics, and dosimetry were studied in normal rats. [(68)Ga]Ga-C803-GIP was stable and demonstrated a high affinity to the huGIPR-HEK293 cells. Binding specificity was demonstrated in vitro in frozen sections of NENs and huGIPR-HEK293 cells. No specific uptake was observed in the negative controls of huGLP1R and huGCGR cells. A novel rationally designed PET radioligand, [(68)Ga]Ga-C803-GIP, demonstrated promising binding characteristics and specificity towards the GIPR. MDPI 2022-12-31 /pmc/articles/PMC9864903/ /pubmed/36678558 http://dx.doi.org/10.3390/ph16010061 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Velikyan, Irina Bossart, Martin Haack, Torsten Laitinen, Iina Estrada, Sergio Johansson, Lars Pierrou, Stefan Wagner, Michael Eriksson, Olof Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences |
title | Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences |
title_full | Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences |
title_fullStr | Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences |
title_full_unstemmed | Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences |
title_short | Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences |
title_sort | imaging of the glucose-dependent insulinotropic polypeptide receptor using a novel radiolabeled peptide rationally designed based on endogenous gip and synthetic exendin-4 sequences |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864903/ https://www.ncbi.nlm.nih.gov/pubmed/36678558 http://dx.doi.org/10.3390/ph16010061 |
work_keys_str_mv | AT velikyanirina imagingoftheglucosedependentinsulinotropicpolypeptidereceptorusinganovelradiolabeledpeptiderationallydesignedbasedonendogenousgipandsyntheticexendin4sequences AT bossartmartin imagingoftheglucosedependentinsulinotropicpolypeptidereceptorusinganovelradiolabeledpeptiderationallydesignedbasedonendogenousgipandsyntheticexendin4sequences AT haacktorsten imagingoftheglucosedependentinsulinotropicpolypeptidereceptorusinganovelradiolabeledpeptiderationallydesignedbasedonendogenousgipandsyntheticexendin4sequences AT laitineniina imagingoftheglucosedependentinsulinotropicpolypeptidereceptorusinganovelradiolabeledpeptiderationallydesignedbasedonendogenousgipandsyntheticexendin4sequences AT estradasergio imagingoftheglucosedependentinsulinotropicpolypeptidereceptorusinganovelradiolabeledpeptiderationallydesignedbasedonendogenousgipandsyntheticexendin4sequences AT johanssonlars imagingoftheglucosedependentinsulinotropicpolypeptidereceptorusinganovelradiolabeledpeptiderationallydesignedbasedonendogenousgipandsyntheticexendin4sequences AT pierroustefan imagingoftheglucosedependentinsulinotropicpolypeptidereceptorusinganovelradiolabeledpeptiderationallydesignedbasedonendogenousgipandsyntheticexendin4sequences AT wagnermichael imagingoftheglucosedependentinsulinotropicpolypeptidereceptorusinganovelradiolabeledpeptiderationallydesignedbasedonendogenousgipandsyntheticexendin4sequences AT erikssonolof imagingoftheglucosedependentinsulinotropicpolypeptidereceptorusinganovelradiolabeledpeptiderationallydesignedbasedonendogenousgipandsyntheticexendin4sequences |